|
Take heed to this text  |
EndoQuest Robotics just lately closed a C-1 most popular financing spherical value $42 million. The Houston-based endoluminal surgical robotic expertise developer earmarked the funding to help its improvement efforts. It expects the funds to gas the development of its versatile endoluminal robotic for minimally invasive procedures.
EndoQuest designed its platform to handle unmet wants in gastrointestinal and different endoluminal surgical procedures. It developed a system that gives precision and adaptability to enhance affected person outcomes. The proprietary expertise navigates and performs procedures inside the physique’s lumina areas, permitting for minimally invasive interventions.
The platform makes it attainable for therapeutic endoscopists and surgeons to function by means of a trans-oral or trans-anal strategy.
Legacy traders CE Ventures Restricted and McNair Pursuits led the financing spherical together with new investor Puma Enterprise Capital. EndoQuest believes the funding displays a vote of confidence in its cutting-edge robotic expertise.
Submit your nominations for innovation awards within the 2024 RBR50 awards.
The corporate expects the newly acquired capital to assist drive key initiatives, comparable to R&D, regulatory milestones and commercialization. It believes the funds strengthen the corporate’s place as “the frontrunner in versatile endoluminal robotics.”
“Our traders share our imaginative and prescient of leveraging robotics to redefine the probabilities in minimally invasive procedures,” stated Kurt Azarbarzin, CEO of EndoQuest Robotics. “This financing allows us to proceed innovating and refining our expertise, finally bettering affected person care and remodeling the way forward for endoluminal interventions.”
“We’re thrilled to affix CE Ventures and McNair Pursuits on this funding spherical for EndoQuest Robotics,” stated Amit Hazan, Co-Founder and Managing Accomplice of Puma Enterprise Capital LLC. Dr. Vipul Patel, a world-renowned robotic urologic surgeon in addition to the Co-Founder and Senior Enterprise Accomplice of Puma Enterprise Capital LLC added, “I’ve had the privilege of seeing nearly each robotic surgical system both in improvement or in the marketplace at the moment and may truthfully say that EndoQuest’s system is a real sport changer for each physicians and sufferers.”
Editor’s Be aware: This text was republished from sister web site MassDevice.
